Mustafa Khasraw (find me in BlueSky)

1.3K posts

Mustafa Khasraw (find me in BlueSky) banner
Mustafa Khasraw (find me in BlueSky)

Mustafa Khasraw (find me in BlueSky)

@MKhasraw

Oncologist @DukeU; interested in cancer research, clinical trials, immunotherapy but many other things - Views are my own

Planet Earth Katılım Mayıs 2019
953 Takip Edilen801 Takipçiler
Mustafa Khasraw (find me in BlueSky) retweetledi
Alireza Mansouri
Alireza Mansouri@DrAMansouri·
Wrapping up marathon of 2025 scientific meetings with a great SNO meeting in Hawaii. Presented latest #ctDNA developments in liquid biopsy space. Moderated an outstanding CNS #metastases oral session. Too little site seeing. Looking forward to opening new trials @PennStNeurosurg. Emerging trans-atlantic collaborations! @AsgeirJakola @DuerinckJohnny @cnsmender @mjlimfat @jasia_mahdi @GeurtsMarjolei @MansouriSheila @Kate_chain @MKhasraw @galldiks @NeuroOnc @PennStNeurosurg @BrainTumorDoc
Alireza Mansouri tweet mediaAlireza Mansouri tweet mediaAlireza Mansouri tweet mediaAlireza Mansouri tweet media
English
2
4
30
783
Mustafa Khasraw (find me in BlueSky) retweetledi
Yair Einhorn
Yair Einhorn@yaireinhorn·
I would strongly advise every American leader and policymaker to listen carefully to @davidrliu - the most important scientist and innovator of our lifetime and the person who invented both Base editing & Prime editing - the 2 top leading modalities of Gene editing, when he describes in @60Minutes the grave danger which the American BioTech ecosystem is facing due to insufficient federal funding. America is already losing its technological and innovative edge! $BEAM $PRME
David R. Liu@davidrliu

Tonight’s episode of @60Minutes will include a segment on the impact of federally funded science and recent cuts to science funding. Our lab’s development of base editing and prime editing and their clinical applications will be among the work described in the episode. paramountpressexpress.com/cbs-news-and-s…

English
14
112
561
172.2K
Mustafa Khasraw (find me in BlueSky) retweetledi
Hussein Tawbi, MD, PhD
Hussein Tawbi, MD, PhD@HTawbi_MD·
Primary results of RELATIVITY-098 showing that adjuvant nivo+rela does not improve RFS over nivo alone, HR 1.01, biomarker data pointing to value of presence of tumor as a potential requirement for LAG3 blockade to improve efficacy. Neoadjuvant Nivo/rela had >60% MPR
Hussein Tawbi, MD, PhD tweet mediaHussein Tawbi, MD, PhD tweet media
English
2
8
25
2.1K
Mustafa Khasraw (find me in BlueSky) retweetledi
Oded Rechavi
Oded Rechavi@OdedRechavi·
Governments to academia:
Oded Rechavi tweet media
English
1
42
230
16.6K
Mustafa Khasraw (find me in BlueSky) retweetledi
Itai Yanai
Itai Yanai@ItaiYanai·
It's a huge honor to be a part of this truly remarkable set of speakers at the Stand Up for Science rally tomorrow in DC in front of the Lincoln Memorial! (My first speech at this kind of an event!)
Itai Yanai tweet media
English
35
54
541
41.4K
Mustafa Khasraw (find me in BlueSky) retweetledi
Alireza Mansouri
Alireza Mansouri@DrAMansouri·
Delighted to share our comprehensive review on leptomeningeal disease now online @NatRevClinOncol Items covered: 1. Distinct pathogenesis of LMD and how it varies from parenchymal brain metastases 2. How cancer cells metabolically in the CSF and evade immune cells 3. Latest advances (and gaps) in our diagnostic approach 4. Up and coming clinical trials for diagnostics and therapeutics 5. How we can learn from past failed studies to put forth standardized approaches And much more! Huge effort by first author and future neurosurgical start @NeuroAhmad Many thanks to all team members: @debaratibhanja @SahgalArjun @MKhasraw @VivekSubbiah @BettegowdaMDPHD @UMDNsgyChair @BrainTumorDoc @NeuroOnc @EANSonline50 @NBTStweets @theABTA @BTNcares @WeTrialshub @NSTumorSection go.nature.com/3VpH543
Alireza Mansouri tweet media
English
4
24
102
11.7K
Mustafa Khasraw (find me in BlueSky) retweetledi
Vivek Subbiah, MD
Vivek Subbiah, MD@VivekSubbiah·
🚨🥁🥁🥁 Hot off the press! @NatRevClinOncol 🚨 Leptomeningeal Metastatic Disease: New Frontiers and Future Directions - Discover groundbreaking insights into LMD in our latest review. ✅From novel diagnostics to cutting-edge therapies like intrathecal and immunotherapies, we explore the path forward in tackling this challenging condition. ✅With advances in mechanistic science and trial design, there's hope on the horizon for improving patient outcomes. 🌟 #LMDResearch #CancerResearch #NeuroOncology #HopeForPatients #precisiononcology #precisionmedicine Kudos to @NeuroAhmad @DrAMansouri @BrainTumorDoc for spearheading this work!!! Many thanks to all co-authors: @debaratibhanja @SahgalArjun @MKhasraw @VivekSubbiah @BettegowdaMDPHD @UMDNsgyChair @NeuroOnc @EANSonline50 @NBTStweets @theABTA @BTNcares @WeTrialshub @NSTumorSection Link: go.nature.com/3VpH543
Alireza Mansouri@DrAMansouri

Delighted to share our comprehensive review on leptomeningeal disease now online @NatRevClinOncol Items covered: 1. Distinct pathogenesis of LMD and how it varies from parenchymal brain metastases 2. How cancer cells metabolically in the CSF and evade immune cells 3. Latest advances (and gaps) in our diagnostic approach 4. Up and coming clinical trials for diagnostics and therapeutics 5. How we can learn from past failed studies to put forth standardized approaches And much more! Huge effort by first author and future neurosurgical start @NeuroAhmad Many thanks to all team members: @debaratibhanja @SahgalArjun @MKhasraw @VivekSubbiah @BettegowdaMDPHD @UMDNsgyChair @BrainTumorDoc @NeuroOnc @EANSonline50 @NBTStweets @theABTA @BTNcares @WeTrialshub @NSTumorSection go.nature.com/3VpH543

English
3
9
31
4.2K

Keşfet

@PennStNeurosurg @AsgeirJakola @DuerinckJohnny @cnsmender @mjlimfat @jasia_mahdi @GeurtsMarjolei @MansouriSheila